Paris - Delayed Quote EUR

Virbac SA (VIRP.PA)

349.00 +2.50 (+0.72%)
At close: April 26 at 5:35 PM GMT+2
Key Events
Loading Chart for VIRP.PA
DELL
  • Previous Close 346.50
  • Open 348.50
  • Bid --
  • Ask --
  • Day's Range 342.00 - 352.00
  • 52 Week Range 232.50 - 377.50
  • Volume 7,198
  • Avg. Volume 4,218
  • Market Cap (intraday) 2.921B
  • Beta (5Y Monthly) 0.90
  • PE Ratio (TTM) 24.70
  • EPS (TTM) 14.13
  • Earnings Date Mar 20, 2024
  • Forward Dividend & Yield 1.32 (0.38%)
  • Ex-Dividend Date Jun 26, 2023
  • 1y Target Est 370.70

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

corporate.virbac.com

5,459

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VIRP.PA

Performance Overview: VIRP.PA

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VIRP.PA
2.92%
CAC 40
7.23%

1-Year Return

VIRP.PA
14.79%
CAC 40
7.39%

3-Year Return

VIRP.PA
27.86%
CAC 40
29.25%

5-Year Return

VIRP.PA
129.15%
CAC 40
45.53%

Compare To: VIRP.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VIRP.PA

Valuation Measures

Annual
As of 4/28/2024
  • Market Cap

    2.92B

  • Enterprise Value

    2.87B

  • Trailing P/E

    24.70

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.44

  • Price/Book (mrq)

    3.25

  • Enterprise Value/Revenue

    2.37

  • Enterprise Value/EBITDA

    12.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.73%

  • Return on Assets (ttm)

    8.34%

  • Return on Equity (ttm)

    13.84%

  • Revenue (ttm)

    1.25B

  • Net Income Avi to Common (ttm)

    121.3M

  • Diluted EPS (ttm)

    14.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    178.4M

  • Total Debt/Equity (mrq)

    13.44%

  • Levered Free Cash Flow (ttm)

    52.91M

Research Analysis: VIRP.PA

Analyst Price Targets

311.00 Low
370.70 Average
349.00 Current
399.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: VIRP.PA

People Also Watch